Cardionovum

Be up
to date.

Latest press release

RESTORE® Drug-Coated Balloon receives first Chinese FDA medical device registration certificate for two indications

RESTORE®, CARDIONOVUM’s innovative paclitaxel-coated balloon for coronary applications has received market approval for China, making it the first drug-coated balloon (DCB) available in China to treat two indications: in-stent restenosis (ISR) and small vessel disease (SVD). The approval was given based on the impressive results from two solidly designed clinical studies in Chinese populations: RESTORE ISR CHINA and RESTORE SVD CHINA.

Learn more >>

J.C. van den Berg discusses results from the APERTO AVF study

Learn more >>

Koen Deloose discusses final results from the Reflow trial

Learn more >>

Matteo Tozzi discusses new data from the APERTO AVF study

Learn more >>

Dr. Bosier interview at LINC 2019

Learn more >>

CARDIONOVUM Press Release: RESTORE® Drug-Coated Balloon Matches Zotarolimus-Eluting Stent in Patients with Coronary Small Vessel Lesions

Learn more >>

Upcoming events

Currently there are no events.

Latest events

Cardionovum® at 31th Erfurter Dialysefachtagung 2023

Cardionovum® is pleased to invite you to visit us at booth #28

Location:

Kaisersaal
Futterstr. 15/16,
99084 Erfurt, Germany

Date: May 04, 2023–May 06, 2023

Cardionovum® at VAS 2023

Cardionovum® is pleased to invite you to visit us at our booth located in the Plenary hall: Exhibition area – A (2nd floor)

Location:

Centro de Congressos da Alfândega do Porto
Rua Nova da Alfândega, 4050-430
Porto, Portugal

Date: Apr 27, 2023–Apr 30, 2023

Cardionovum® at Deutschen Gesellschaft für Kardiologie (DGK) 2023

Cardionovum® is glad to invite you to visit us at booth #017

Location:

Congress Center Rosengarten Mannheim (CCR)
Rosengartenplatz 2, 68161
Mannheim, Germany

Date: Apr 12, 2023–Apr 16, 2023

go top